Non-ionic triiodinated contrast media, 240 mg of iodine/ml
This tender has been awarded
Awarded to Bayer S.A.; Bracco Imaging Europe B.V.; GE HealthCare B.V.; Guerbet S.A. — €2,940,000
About This Opportunity
TranslatedThis tender concerns the supply of non-ionic triiodinated contrast agents, specifically those containing 240 mg of iodine per milliliter. The required products are available in three different volumes: 10 ml, 20 ml, and 50 ml. These agents are crucial for various medical imaging procedures, particularly in radiology, where they are used to enhance the visibility of internal body structures. The specification of 'non-ionic' indicates a preference for agents that do not dissociate into ions when in solution, which generally leads to better patient tolerance and a reduced risk of adverse reactions compared to ionic contrast media. The concentration of 240 mg iodine/ml is a key technical parameter ensuring a specific level of radiopacity. The availability in multiple vial sizes (10 ml, 20 ml, 50 ml) suggests a need for flexibility in usage, catering to different procedural requirements and patient volumes. Procurement of such specialized medical supplies is vital for healthcare facilities to maintain their diagnostic capabilities and ensure high-quality patient care. Further details regarding quantities, delivery schedules, and specific quality standards are expected to be outlined in the full tender documentation. This procurement falls under the healthcare sector, focusing on diagnostic imaging consumables.
This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals and Medical Equipment. Located in Luxembourg, Europe, this opportunity is open to firms and consortiums.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Auto-translated from FrenchThis tender, originating from Luxembourg, seeks the supply of non-ionic triiodinated contrast media. The procurement specifically requires these agents to contain 240 mg of iodine per milliliter. The contract will encompass the provision of these contrast media in three distinct volume formats: 10 ml, 20 ml, and 50 ml.
This procurement falls under the category of medical supplies and pharmaceuticals, specifically targeting products used in diagnostic imaging procedures. Non-ionic contrast agents are widely utilized in various radiological examinations, including computed tomography (CT) scans and angiography, due to their favorable safety profiles and efficacy in enhancing image visualization.
Potential bidders are expected to demonstrate their capacity to supply high-quality, pharmaceutical-grade contrast media that meet stringent regulatory and quality standards. Typical requirements for such tenders include detailed product specifications, evidence of Good Manufacturing Practice (GMP) compliance, relevant certifications, and robust supply chain management capabilities to ensure timely and reliable delivery. Bidders will likely need to provide information regarding their manufacturing facilities, quality control processes, and product stability data. Furthermore, a comprehensive understanding of European Union regulations pertaining to medical devices and pharmaceuticals will be essential. The contracting authority, managed by the Publications Office of the European Union, will be evaluating proposals based on technical merit, quality assurance, and competitive pricing.
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on March 17, 2025. Last refreshed 9 days ago. Original language: French. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Fédération des Hôpitaux Luxembourgeois
Fédération des Hôpitaux Luxembourgeois has issued 4 procurement notices on BidsFactory, including 0 currently open and 3 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Luxembourg. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: August 13, 2026.
Frequently asked questions about this tender
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to Bayer S.A.; Bracco Imaging Europe B.V.; GE HealthCare B.V.; Guerbet S.A.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Fédération des Hôpitaux Luxembourgeois in Luxembourg. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
Bayer S.A.; Bracco Imaging Europe B.V.; GE HealthCare B.V.; Guerbet S.A. was awarded the contract for €2,940,000. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Luxembourg. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.